About this document

Injectable Lenacapavir: HIV Prevention Breakthrough by zulusinaye254 is a document available to read on EtoBox.

Lenacapavir, an injectable HIV drug, has shown remarkable efficacy in preventing infections, achieving 100% efficacy in trials among adolescent girls and young women, and 99.9% in gender-diverse individuals. This breakthrough offers hope for reducing global HIV infection rates, particularly as a pre-exposure prophylaxis (PrEP), although its success depends on accessibility and affordability. Despite its potential, lenacapavir is not a substitute for a vaccine, which remains crucial for broader immunity agai

Author

zulusinaye254

Language

EN